06-12-2018 дата публикации
Номер: US20180346592A1
Автор:
Choi Soongyu,
KIM Dong-Sik,
Kim Kisu,
KIM SUJEONG,
LEE Eun-Hee,
Lee Kyuhyun,
LEE Mijung,
Lim Hyung-Kwon,
PARK Jae Chan,
PARK Young Seoub,
Song Eun Jung,
WON Jongwha
Принадлежит:
The present invention relates to an antibody specifically binding to glypican 3 (GPC3), a nucleic acid encoding the antibody, a vector and a host cell containing the nucleic acid, a method of preparing the antibody, and a pharmaceutical composition for treating cancer or tumor, containing the antibody as an active ingredient. The antibody specifically binding to glypican 3 according to the present invention may be effectively used to treat cancer or tumor, particularly, hepatocellular carcinoma due to high affinity and specificity to glypican 3. 1. An anti-glypican 3 antibody comprising a heavy chain variable region comprising the following heavy chain CDRs:a heavy chain CDR1 comprising an amino acid sequence of SEQ ID NO: 133, 143, 149, 159, 169, 174, 184, 199, 262, 268, 273, 281, 285, 291, 297, 308, 353, 363, 374, 380, or 386;a heavy chain CDR2 comprising an amino acid sequence of SEQ ID NO:134, 144, 150, 160, 170, 175, 185, 200, 231, 263, 266, 269, 274, 282, 286, 292, 298, 303, 309, 314, 318, 323, 328, 331, 336, 341, 345, 349, 354, 359, 364, 369, 375, 381, or 387; anda heavy chain CDR3 comprising an amino acid sequence of SEQ ID NO: 135, 139, 145, 151, 155, 161, 165, 171, 176, 180, 186, 189, 194, 195, 201, 205, 207, 210, 214, 218, 222, 227, 232, 237, 239, 243, 247, 250, 254, 258, 259, 264, 267, 270, 275, 278, 279, 283, 287, 293, 299, 304, 310, 315, 319, 324, 329, 332, 337, 342, 346, 350, 355, 360, 365, 370, 376, 382, or 388, ora light chain variable region comprising the following light chain CDRs:a light chain CDR1 comprising an amino acid sequence of SEQ ID NO: 136, 140, 146, 152, 156, 162, 166, 172, 177, 181, 187, 190, 193, 196, 202, 208, 211, 215, 219, 223, 224, 228, 233, 240, 244, 251, 255, 260, 265, 271, 288, 294, 300, 305, 311, 316, 320, 325, 333, 338, 343, 347, 356, 361, 366, 371, 377, 383, or 389;a light chain CDR2 comprising an amino acid sequence of SEQ ID NO: 137, 141, 147, 153, 157, 163, 167, 178, 182, 191, 197, 203, 209, 212, 216, 220, 225, 229, 234 ...
Подробнее